Borisova E V, Kochetkov A I, Ostroumova O D
A. I. Yevdokimov Moscow State University of Medicine and Dentistry City Clinical Hospital named after E. O. Mukhin.
A. I. Yevdokimov Moscow State University of Medicine and Dentistry.
Kardiologiia. 2019 Apr 12;59(3):18-26. doi: 10.18087/cardio.2019.3.10236.
to investigate the impact of indapamide / perindopril single-pill combination (I / P SPC) on arterial stiffness parameters, blood pressure (BP) level and BP variability (BPV) in middle-aged patients with stage II grade 1-2 essential arterial hypertension (EAH). Materials and methods. We retrospectively formed a group of patients with stage II grade 1-2 EAH who had not previously received regular antihypertensive therapy (AHT) (n=52, mean age 52.9±6.0 years). All patients were treated with I / P SPC and all of them achieved target office BP level (less than 140 / 90 mm Hg). After 12 weeks of follow-up (from the time of reaching the target BP) assessment of AHT effectiveness (general clinical data, ambulatory blood pressure monitoring [ABPM], volume sphygmography, echocardiography), and vascular stiffness evaluation were performed.
At the end of follow-up office systolic BP (SBP), diastolic BP (DBP), pulse BP, day-time, night-time and 24‑hour SBP and DBP significantly (p<0.001 for all) decreased. According to the ABPM data day-time, nighttime, and 24‑hour systolic BPV significantly decreased (p=0.029, p=0.006 and p<0.001, respectively); day-time and 24‑hour diastolic BPV also significantly decreased (p=0.001 and p<0.001, respectively). Day-night standard deviation (SDdn) significantly decreased too (p=0.002 and p<0.001, respectively). Volumetric sphygmography showed significant decrease of right cardio-ankle vascular index (CAVI) (from 8.20±1.29 to 7.58±1.44, p=0.001) and of left CAVI (from 8.13±1.40 to 7.46±1.43, p<0.001), as well as reduction of the number o f patients with a right- and / or left-CAVI >9.0 (from 32.7 to 11.5 %, p=0.018). According to assessment of arterial stiffness using the Vasotens24 software package, the arterial stiffness index (ASI) significantly (p<0.001) decreased from 153.5±29.9 to 138.3±20.0 (by -9.2±13.1 %). Transthoracic echocardiography data demonstrated significant decrease (p<0.001) in effective arterial elastance (from 1.82±0.43 to 1.58±0.36 mm Hg; by -11.85±16.29 %) and significant (p<0.001) increase in the arterial compliance - from 1.27±0.34 to 1.54±0.38 mm Hg / ml (+26.95±38.06 %).
In AHT naive patients 40-65 years old with stage II grade 1-2 EAH therapy with I / P SPC provided effective 24‑hour BP control, reduced BPV and improved arterial stiffness parameters.
探讨吲达帕胺/培哚普利单片复方制剂(I/P SPC)对中年II期1-2级原发性高血压(EAH)患者动脉僵硬度参数、血压(BP)水平及血压变异性(BPV)的影响。材料与方法。我们回顾性地选取了一组此前未接受过正规降压治疗(AHT)的II期1-2级EAH患者(n = 52,平均年龄52.9±6.0岁)。所有患者均接受I/P SPC治疗,且所有患者均达到诊室血压目标水平(低于140/90 mmHg)。在随访12周后(从达到目标血压时起),对AHT疗效(一般临床数据、动态血压监测[ABPM]、容积脉搏波描记法、超声心动图)进行评估,并进行血管僵硬度评估。
随访结束时,诊室收缩压(SBP)、舒张压(DBP)、脉压、日间、夜间及24小时SBP和DBP均显著降低(所有p<0.001)。根据ABPM数据,日间、夜间及24小时收缩压变异性显著降低(分别为p = 0.029、p = 0.006及p<0.001);日间及24小时舒张压变异性也显著降低(分别为p = 0.001及p<0.001)。昼夜标准差(SDdn)也显著降低(分别为p = 0.002及p<0.001)。容积脉搏波描记法显示右心踝血管指数(CAVI)显著降低(从8.20±1.29降至7.58±1.44,p = 0.001),左CAVI也显著降低(从8.13±1.40降至7.46±1.43,p<0.001),且右和/或左CAVI>9.0的患者数量减少(从32.7%降至11.5%,p = 0.018)。根据使用Vasotens24软件包对动脉僵硬度的评估,动脉僵硬度指数(ASI)显著降低(p<0.001),从153.5±29.9降至138.3±20.0(降低了-9.2±13.1%)。经胸超声心动图数据显示有效动脉弹性显著降低(p<0.001)(从1.82±0.43降至1.58±0.36 mmHg;降低了-11.85±16.29%),动脉顺应性显著增加(p<0.001)(从1.27±0.34升至1.54±0.38 mmHg/ml(增加了+26.95±38.06%)。
在40-65岁未接受过AHT的II期1-2级EAH患者中,I/P SPC治疗可实现有效的24小时血压控制,降低BPV并改善动脉僵硬度参数。